Authors: Mollgard, L Hellberg, E Smolowicz, A Paul, C Tidefelt, U

Citation: L. Mollgard et al., Interactions between P-glycoprotein and drugs used in the supportive care of acute myeloid leukemia patients, LEUK LYMPH, 42(1-2), 2001, pp. 177-185

Authors: Uggla, B Mollgard, L Stahl, E Mossberg, LL Karlsson, MG Paul, C Tidefelt, U

Citation: B. Uggla et al., Expression of topoisomerase II alpha in the G0/G1 cell cycle phase of fresh leukemic cells, LEUK RES, 25(11), 2001, pp. 961-966

Authors: Tidefelt, U Liliemark, J Gruber, A Liliemark, E Sundman-Engberg, B Juliusson, G Stenke, L Elmhorn-Rosenborg, A Mollgard, L Lehman, S Xu, D Covelli, A Gustavsson, B Paul, C

Citation: U. Tidefelt et al., P-glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with p-glycoprotein-positive acute myeloid leukemia, J CL ONCOL, 18(9), 2000, pp. 1837-1844

Authors: Mollgard, L Tidefelt, U Sundman-Engberg, B Lofgren, C Paul, C

Citation: L. Mollgard et al., In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay, LEUK RES, 24(5), 2000, pp. 445-452